{"title":"伏氏针刺治疗颈椎病的疗效和安全性：基于随机对照试验的系统评价和meta分析。","authors":"Yating Shen, Jing Chen, Sen Tang, Binbin Xiao","doi":"10.2147/JPR.S530364","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Spondylosis (CS) is a prevalent condition that significantly impacts quality of life and overall health. Fu's subcutaneous needling, a novel acupuncture technique, has been widely used to treat CS. This study employs a meta-analysis to comprehensively evaluate the efficacy of Fu's subcutaneous needling in treating CS.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Science Periodical Database (CSPD), Chinese Citation Database (CCD), and Chinese biomedical literature service system (CBM) databases for clinical trials on Fu's subcutaneous needling for CS, from inception to March 1, 2025. The quality of the included studies was assessed using the Cochrane Handbook for Systematic Reviews, and meta-analysis was performed using Stata 16.0.</p><p><strong>Results: </strong>A total of 46 studies involving 3767 cases were included. The results showed that the Fu's subcutaneous needling group had a higher effective rate than the control group (RR: 1.17, 95% CI: 1.14-1.20, p < 0.05). The Fu's subcutaneous needling group also had lower Visual Analog Scale (VAS) scores (WMD: -1.55, 95% CI: -1.98 to -1.12, p < 0.05), lower Northwick Park Neck Pain Questionnaire (NPQ) scores (WMD: -2.65, 95% CI: -5.27 to -0.03, p < 0.05), and lower Neck Disability Index (NDI) scores (WMD: -3.40, 95% CI: -6.59 to -0.21, p < 0.05) compared to the control group. The Fu's subcutaneous needling group also demonstrated higher safety (RR: 0.32, 95% CI: 0.13-0.75, p < 0.05). Subgroup analysis indicated that Fu's subcutaneous needling was effective across various subtypes of CS and showed significant advantages over other treatment modalities. The Efficacy of Fu's subcutaneous needling improved with longer treatment durations.</p><p><strong>Conclusion: </strong>Fu's subcutaneous needling is effective and safe for treating CS. Due to the limited number of included studies, further research is needed to confirm these findings.</p>","PeriodicalId":16661,"journal":{"name":"Journal of Pain Research","volume":"18 ","pages":"4759-4774"},"PeriodicalIF":2.5000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439692/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Fu's Subcutaneous Needling in the Treatment of Cervical Spondylosis: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.\",\"authors\":\"Yating Shen, Jing Chen, Sen Tang, Binbin Xiao\",\"doi\":\"10.2147/JPR.S530364\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Spondylosis (CS) is a prevalent condition that significantly impacts quality of life and overall health. Fu's subcutaneous needling, a novel acupuncture technique, has been widely used to treat CS. This study employs a meta-analysis to comprehensively evaluate the efficacy of Fu's subcutaneous needling in treating CS.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Science Periodical Database (CSPD), Chinese Citation Database (CCD), and Chinese biomedical literature service system (CBM) databases for clinical trials on Fu's subcutaneous needling for CS, from inception to March 1, 2025. The quality of the included studies was assessed using the Cochrane Handbook for Systematic Reviews, and meta-analysis was performed using Stata 16.0.</p><p><strong>Results: </strong>A total of 46 studies involving 3767 cases were included. The results showed that the Fu's subcutaneous needling group had a higher effective rate than the control group (RR: 1.17, 95% CI: 1.14-1.20, p < 0.05). The Fu's subcutaneous needling group also had lower Visual Analog Scale (VAS) scores (WMD: -1.55, 95% CI: -1.98 to -1.12, p < 0.05), lower Northwick Park Neck Pain Questionnaire (NPQ) scores (WMD: -2.65, 95% CI: -5.27 to -0.03, p < 0.05), and lower Neck Disability Index (NDI) scores (WMD: -3.40, 95% CI: -6.59 to -0.21, p < 0.05) compared to the control group. The Fu's subcutaneous needling group also demonstrated higher safety (RR: 0.32, 95% CI: 0.13-0.75, p < 0.05). Subgroup analysis indicated that Fu's subcutaneous needling was effective across various subtypes of CS and showed significant advantages over other treatment modalities. The Efficacy of Fu's subcutaneous needling improved with longer treatment durations.</p><p><strong>Conclusion: </strong>Fu's subcutaneous needling is effective and safe for treating CS. Due to the limited number of included studies, further research is needed to confirm these findings.</p>\",\"PeriodicalId\":16661,\"journal\":{\"name\":\"Journal of Pain Research\",\"volume\":\"18 \",\"pages\":\"4759-4774\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12439692/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pain Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/JPR.S530364\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JPR.S530364","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景：颈椎病（CS）是一种显著影响生活质量和整体健康的普遍疾病。Fu’s皮下针刺是一种新型的针刺技术，已广泛应用于颈椎病的治疗。本研究采用meta分析综合评价Fu’s皮下针刺治疗CS的疗效。方法：检索PubMed、Web of Science、Embase、Cochrane Library、中国知网（CNKI）、中国科学期刊数据库（CSPD）、中国引文数据库（CCD）和中国生物医学文献服务系统（CBM）数据库，检索自成立至2025年3月1日Fu’s皮下针治疗CS的临床试验。使用Cochrane系统评价手册评估纳入研究的质量，使用Stata 16.0进行meta分析。结果：共纳入46项研究，共3767例。结果显示，Fu’s皮下针刺组有效率高于对照组（RR: 1.17, 95% CI: 1.14 ~ 1.20, p < 0.05）。与对照组相比，Fu’s皮下针刺组的视觉模拟量表（VAS）评分（WMD: -1.55, 95% CI: -1.98 ~ -1.12, p < 0.05）、Northwick Park颈部疼痛问卷（NPQ）评分（WMD: -2.65, 95% CI: -5.27 ~ -0.03, p < 0.05）和颈部残疾指数（NDI）评分（WMD: -3.40, 95% CI: -6.59 ~ -0.21, p < 0.05）也较低。Fu’s皮下针刺组也表现出更高的安全性（RR: 0.32, 95% CI: 0.13-0.75, p < 0.05）。亚组分析表明Fu的皮下针刺对不同类型的CS有效，并且比其他治疗方式具有显著优势。随着治疗时间的延长，付氏针的治疗效果也有所提高。结论：付氏针法治疗颈椎病安全有效。由于纳入的研究数量有限，需要进一步的研究来证实这些发现。
Efficacy and Safety of Fu's Subcutaneous Needling in the Treatment of Cervical Spondylosis: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
Background: Spondylosis (CS) is a prevalent condition that significantly impacts quality of life and overall health. Fu's subcutaneous needling, a novel acupuncture technique, has been widely used to treat CS. This study employs a meta-analysis to comprehensively evaluate the efficacy of Fu's subcutaneous needling in treating CS.
Methods: We searched PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), China Science Periodical Database (CSPD), Chinese Citation Database (CCD), and Chinese biomedical literature service system (CBM) databases for clinical trials on Fu's subcutaneous needling for CS, from inception to March 1, 2025. The quality of the included studies was assessed using the Cochrane Handbook for Systematic Reviews, and meta-analysis was performed using Stata 16.0.
Results: A total of 46 studies involving 3767 cases were included. The results showed that the Fu's subcutaneous needling group had a higher effective rate than the control group (RR: 1.17, 95% CI: 1.14-1.20, p < 0.05). The Fu's subcutaneous needling group also had lower Visual Analog Scale (VAS) scores (WMD: -1.55, 95% CI: -1.98 to -1.12, p < 0.05), lower Northwick Park Neck Pain Questionnaire (NPQ) scores (WMD: -2.65, 95% CI: -5.27 to -0.03, p < 0.05), and lower Neck Disability Index (NDI) scores (WMD: -3.40, 95% CI: -6.59 to -0.21, p < 0.05) compared to the control group. The Fu's subcutaneous needling group also demonstrated higher safety (RR: 0.32, 95% CI: 0.13-0.75, p < 0.05). Subgroup analysis indicated that Fu's subcutaneous needling was effective across various subtypes of CS and showed significant advantages over other treatment modalities. The Efficacy of Fu's subcutaneous needling improved with longer treatment durations.
Conclusion: Fu's subcutaneous needling is effective and safe for treating CS. Due to the limited number of included studies, further research is needed to confirm these findings.
期刊介绍：
Journal of Pain Research is an international, peer-reviewed, open access journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain. Original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication. Additionally, the journal now welcomes the submission of pain-policy-related editorials and commentaries, particularly in regard to ethical, regulatory, forensic, and other legal issues in pain medicine, and to the education of pain practitioners and researchers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
